The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: The possible role of suppressors of cytokine signaling proteins

Journal of Neuroimmunology

Volumn 276, Issue 1-2, 2014, Pages 37-46

  Szczesny, Ewa ^a   Basta Kaim, Agnieszka ^a   Slusarczyk, Joanna ^a   Trojan, Ewa ^a   Glombik, Katarzyna ^a   Regulska, Magdalena ^a   Leskiewicz, Monika ^a   Budziszewska, Boguslawa ^a   Kubera, Marta ^a   Lason, Wladyslaw ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Depression; Insulin like growth factor 1; Prenatal stress; Pro inflammatory cytokines; Suppressor of cytokine signaling

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INSULIN-LIKE GROWTH FACTOR-1, RAT; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; EVOKED RESPONSE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRENATAL STRESS; PROGENY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; MAZE TEST; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY; SPRAGUE DAWLEY RAT; SWIMMING;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CYTOKINES; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84908574862     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.08.001     Document Type: Article

References (60)

1. Aisa B., Elizalde N., Tordera R., Lasheras B., Del Río J., Ramírez M.J. Effects of neonatal stress on markers of synaptic plasticity in the hippocampus: implications for spatial memory. Hippocampus 2009, 19:1222-1231.
2. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 2005, 90:2522-2530.
3. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metcalf D., Hilton D.J. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999, 98:597-608.
4. Baquedano E., García-Cáceres C., Diz-Chaves Y., Lagunas N., Calmarza-Font I., Azcoitia I., Garcia-Segura L.M., Argente J., Chowen J.A., Frago L.M. Prenatal stress induces long-term effects in cell turnover in the hippocampus-hypothalamus-pituitary axis in adult male rats. PLoS One 2011, 6:e27549.
5. Basta-Kaim A., Szczesny E., Glombik K., Stachowicz K., Slusarczyk J., Nalepa I., Zelek-Molik A., Rafa-Zablocka K., Budziszewska B., Kubera M., Leskiewicz M., Lason W. Prenatal stress affects insulin-like growth factor-1 (IGF-1) level and IGF-1 receptor phosphorylation in the brain of adult rats. Eur Neuropsychopharmacol. 2014, 281-283. (in press). 10.1016/j.euroneuro.2014.07.002.
6. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 2002, 168:6404-6411.
7. Bluthé R.M., Dantzer R., Kelley K.W. Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor alpha in mice. Eur. J. Pharmacol. 1991, 209:281-283.
8. Bluthé R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., Dantzer R. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 1994, 19:197-207.
9. Bluthé R.M., Kelley K.W., Dantzer R. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav. Immun. 2006, 20:57-63.
10. Branchi I., Francia N., Alleva E. Epigenetic control of neurobehavioural plasticity: the role of neurotrophins. Behav. Pharmacol. 2004, 15:353-362.
11. Broussard S.R., McCusker R.H., Novakofski J.E., Strle K., Shen W.H., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 2003, 144:2988-2996.
12. Broussard S.R., McCusker R.H., Novakofski J.E., Strle K., Shen W.H., Johnson R.W., Dantzer R., Kelley K.W. IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts. J. Immunol. 2004, 172:7713-7720.
13. Budziszewska B., Szymanska M., Leskiewicz M., Basta-Kaim A., Jaworska-Feil L., Kubera M., Jantas D., Lason W. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J. Physiol. Pharmacol. 2010, 61:207-215.
14. Campbell I.L. Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res. Rev. 2005, 48:166-177.
15. Dantzer R., Gheusi G., Johnson R.W., Kelley K.W. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport 1999, 10:289-292.
16. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
17. Dey B.R., Spence S.L., Nissley P., Furlanetto R.W. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 1998, 273:24095-24101.
18. Ding Y., Chen D., Tarcsafalvi A., Su R., Qin L., Bromberg J.S. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 2003, 170:1383-1391.
19. Diz-Chaves Y., Pernía O., Carrero P., Garcia-Segura L.M. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J. Neuroinflammation 2012, 9:71.
20. Diz-Chaves Y., Astiz M., Bellini M.J., Garcia-Segura L.M. Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice. Brain Behav. Immun. 2013, 28:196-206.
21. Dominici F.P., Argentino D.P., Muñoz M.C., Miquet J.G., Sotelo A.I., Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm. IGF Res. 2005, 15:324-336.
22. Downer E.J., Cowley T.R., Cox F., Maher F.O., Berezin V., Bock E., Lynch M.A. A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation. J. Neurochem. 2009, 109:1516-1525.
23. Duman C.H., Schlesinger L., Terwilliger R., Russell D.S., Newton S.S., Duman R.S. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav. Brain Res. 2009, 198:366-371.
24. Dunn A.J., Swiergiela A.H., de Beaurepairec R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 2005, 29:891-909.
25. Gingras S., Parganas E., de Pauw A., Ihle J.N., Murray P.J. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. J. Biol. Chem. 2004, 279:54702-54707.
26. Greenhalgh C.J., Bertolino P., Asa S.L., Metcalf D., Corbin J.E., Adams T.E., Davey H.W., Nicola N.A., Hilton D.J., Alexander W.S. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol. Endocrinol. 2002, 16:1394-1406.
27. Hopp S.C., Royer S., Brothers H.M., Kaercher R.M., D'Angelo H., Bardou I., Wenk G.L. Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β. J. Neuroimmunol. 2014, 267:86-91.
28. Kohman R.A., Tarr A.J., Day C.E., McLinden K.A., Boehm G.W. Influence of prenatal stress on behavioral, endocrine, and cytokine responses to adulthood bacterial endotoxin exposure. Behav. Brain Res. 2008, 193:257-268.
29. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999, 818:291-303.
30. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000, 22:370-379.
31. Laviola G., Rea M., Morley-Fletcher S., Di Carlo S., Bacosi A., De Simone R., Bertini M., Pacifici R. Beneficial effects of enriched environment on adolescent rats from stressed pregnancies. Eur. J. Neurosci. 2004, 20:1655-1664.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
33. Maccari S., Morley-Fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 2007, 32(Suppl. 1):S10-S15.
34. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., Aliberti J. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 2006, 12:330-334.
35. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 1999, 461:25-46.
36. Mairesse J., Silletti V., Laloux C., Zuena A.R., Giovine A., Consolazione M., van Camp G., Malagodi M., Gaetani S., Cianci S., Catalani A., Mennuni G., Mazzetta A., van Reeth O., Gabriel C., Mocaër E., Nicoletti F., Morley-Fletcher S., Maccari S. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. Int. J. Neuropsychopharmacol. 2013, 16:323-338.
37. McNamee E.N., Ryan K.M., Griffin E.W., González-Reyes R.E., Ryan K.J., Harkin A., Connor T.J. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration. Brain Behav. Immun. 2010, 24:660-671.
38. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90:285-326.
39. Mitschelen M., Yan H., Farley J.A., Warrington J.P., Han S., Hereñú C.B., Csiszar A., Ungvari Z., Bailey-Downs L.C., Bass C.E., Sonntag W.E. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression. Neuroscience 2011, 185:50-60.
40. Palin K., Bluthé R.M., McCusker R.H., Moos F., Dantzer R., Kelley K.W. TNFalpha-induced sickness behavior in mice with functional 55kD TNF receptors is blocked by central IGF-I. J. Neuroimmunol. 2007, 187:55-60.
41. Park S.E., Lawson M., Dantzer R., Kelley K.W., McCusker R.H. Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. J. Neuroinflammation 2011, 8:179.
42. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14:149-167.
43. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
44. Qin H., Niyongere S.A., Lee S.J., Baker B.J., Benveniste E.N. Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J. Immunol. 2008, 181:3167-3176.
45. Raghavendra Rao V.L., Bowen K.K., Dhodda V.K., Song G., Franklin J.L., Gavva N.R., Dempsey R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 2002, 83:1072-1086.
46. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
47. Rico-Bautista E., Flores-Morales A., Fernández-Pérez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev. 2006, 17:431-439.
48. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
49. Sluzewska A., Sobieska M., Rybakowski J.K. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 1997, 35:123-127.
50. Strle K., Broussard S.R., McCusker R.H., Shen W.H., LeCleir J.M., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. Endocrinology 2006, 147:4363-4373.
51. Suh H.S., Zhao M.L., Derico L., Choi N., Lee S.C. Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J. Neuroinflammation 2013, 10:37.
52. Szymanska M., Budziszewska B., Jaworska-Feil L., Basta-Kaim A., Kubera M., Leskiewicz M., Regulska M., Lason W. The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats. Psychoneuroendocrinology 2009, 34:822-832.
53. Szymańska M., Suska A., Budziszewska B., Jaworska-Feil L., Basta-Kaim A., Leśkiewicz M., Kubera M., Gegont A., Kroczka S., Kaciński M., Lasoń W. Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex. Pharmacol. Rep. 2009, 61:612-620.
54. Tiemeier H., Hofman A., van Tuijl H.R., Kiliaan A.J., Meijer J., Breteler M.M. Inflammatory proteins and depression in the elderly. Epidemiology 2003, 14:103-107.
55. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 2010, 70:384-396.
56. Trejo J.L., Carro E., Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 2001, 21:1628-1634.
57. Venters H.D., Dantzer R., Kelley K.W. Tumor necrosis factor-alpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann. N. Y. Acad. Sci. 2000, 917:210-220.
58. Wang P., Li N., Li J.S., Li W.Q. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J. Gastroenterol. 2002, 8:531-536.
59. Wang J., Schreiber R.D., Campbell I.L. STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16209-16214.
60. Ye P., Price W., Kassiotis G., Kollias G., D'Ercole A.J. Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice. J. Neurosci. Res. 2003, 71:721-731.